What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Guo-Yuan Yang mainly focuses on Ischemia, Pathology, Angiogenesis, Internal medicine and Brain ischemia.
His Ischemia study combines topics in areas such as Stroke, Pharmacology, Edema and Cerebral edema.
His work carried out in the field of Pathology brings together such families of science as Interleukin 1 receptor antagonist, Receptor antagonist and Astrocyte.
The study incorporates disciplines such as Progenitor cell, Vascular endothelial growth factor, Arteriovenous malformation, Cell biology and Endothelium in addition to Angiogenesis.
His studies in Internal medicine integrate themes in fields like Endocrinology and microRNA.
His Brain ischemia research incorporates elements of Hippocampal formation, Brain damage, Cerebral cortex, Neuroscience and Caspase.
His most cited work include:
- Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. (510 citations)
- Experimental intracerebral hemorrhage : relationship between brain edema, blood flow, and blood-brain barrier permeability in rats (328 citations)
- Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. (318 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Ischemia, Pathology, Angiogenesis, Internal medicine and Stroke.
He has researched Ischemia in several fields, including Anesthesia, Cerebral blood flow and Pharmacology.
His Pathology research is multidisciplinary, relying on both Inflammation, Central nervous system, Neuroprotection and Transplantation.
He combines subjects such as Neurogenesis, Vascular endothelial growth factor and Progenitor cell with his study of Angiogenesis.
His Vascular endothelial growth factor study integrates concerns from other disciplines, such as Matrix metalloproteinase and Growth factor.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Immunology and Cardiology.
He most often published in these fields:
- Ischemia (35.83%)
- Pathology (33.02%)
- Angiogenesis (25.23%)
What were the highlights of his more recent work (between 2018-2021)?
- Ischemia (35.83%)
- Stroke (17.13%)
- Internal medicine (20.25%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Ischemia, Stroke, Internal medicine, Pharmacology and Neuroprotection.
He works in the field of Ischemia, namely Brain ischemia.
His research in Internal medicine tackles topics such as Cardiology which are related to areas like Angiography and Ultrasound.
His Pharmacology research includes elements of Oxidative stress and Ghrelin.
His work deals with themes such as Endocrinology, Blood–brain barrier and Viability assay, Apoptosis, Programmed cell death, which intersect with Neuroprotection.
The various areas that Guo-Yuan Yang examines in his Angiogenesis study include Vascular endothelial growth factor, Pathology, Sonic hedgehog, Tube formation and In vivo.
Between 2018 and 2021, his most popular works were:
- M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124. (53 citations)
- Optimal design and performance analysis of solar hybrid CCHP system considering influence of building type and climate condition (33 citations)
- Significance of Complement System in Ischemic Stroke: A Comprehensive Review (27 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His primary areas of study are Ischemia, Pharmacology, Stroke, Brain ischemia and Neuroprotection.
His research integrates issues of Receptor, Angiogenesis, microRNA and Edema in his study of Ischemia.
His Stroke study is concerned with the larger field of Internal medicine.
Guo-Yuan Yang has included themes like Exosome, Microvesicles, Reperfusion injury, Neurogenesis and Programmed cell death in his Brain ischemia study.
His Proinflammatory cytokine research is multidisciplinary, incorporating elements of Blood–brain barrier and Pathology.
His study in the field of Neuroinflammation also crosses realms of Vascular dementia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
